NO893387L - Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering. - Google Patents
Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering.Info
- Publication number
- NO893387L NO893387L NO89893387A NO893387A NO893387L NO 893387 L NO893387 L NO 893387L NO 89893387 A NO89893387 A NO 89893387A NO 893387 A NO893387 A NO 893387A NO 893387 L NO893387 L NO 893387L
- Authority
- NO
- Norway
- Prior art keywords
- somatotropines
- mutagenese
- cyste
- restrictions
- stabilization
- Prior art date
Links
- 238000001212 derivatisation Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000006641 stabilisation Effects 0.000 title 1
- 238000011105 stabilization Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23606088A | 1988-08-24 | 1988-08-24 | |
US37269989A | 1989-07-03 | 1989-07-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO893387D0 NO893387D0 (no) | 1989-08-23 |
NO893387L true NO893387L (no) | 1990-02-26 |
Family
ID=26929421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89893387A NO893387L (no) | 1988-08-24 | 1989-08-23 | Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5891840A (no) |
EP (1) | EP0355460B1 (no) |
JP (1) | JP2894355B2 (no) |
AR (1) | AR245138A1 (no) |
AT (1) | ATE198353T1 (no) |
AU (1) | AU630105B2 (no) |
DE (1) | DE68929273T2 (no) |
DK (1) | DK416589A (no) |
ES (1) | ES2154627T3 (no) |
FI (1) | FI104908B (no) |
GR (1) | GR3035608T3 (no) |
HU (1) | HU217095B (no) |
IE (1) | IE892706A1 (no) |
IL (1) | IL91156A (no) |
NO (1) | NO893387L (no) |
NZ (1) | NZ230342A (no) |
PT (1) | PT91512B (no) |
YU (1) | YU163289A (no) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2580303B2 (ja) * | 1987-02-19 | 1997-02-12 | ジ・アップジョン・カンパニー | 異種蛋白をコ−ド付けするcDNA類、発現ベクタ−類および宿主類 |
US5089473A (en) * | 1988-08-29 | 1992-02-18 | Monsanto Company | Somatotropin variants and their use |
US5079230A (en) * | 1988-09-12 | 1992-01-07 | Pitman-Moore, Inc. | Stable bioactive somatotropins |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US5951972A (en) * | 1990-05-04 | 1999-09-14 | American Cyanamid Company | Stabilization of somatotropins and other proteins by modification of cysteine residues |
ATE163431T1 (de) * | 1990-05-04 | 1998-03-15 | American Cyanamid Co | Stabilisierung von somatotropin durch modifizierung von cysteinsresten |
DK168790D0 (no) * | 1990-07-13 | 1990-07-13 | Novo Nordisk As | |
US6894023B1 (en) | 1990-07-13 | 2005-05-17 | Novo Nordisk A/S | Growth hormone crystals and a process for production of these GH-crystals |
US5780599A (en) * | 1990-07-13 | 1998-07-14 | Novo Nordisk A/S | Growth hormone crystals and a process for production of growth hormone crystals |
US5849694A (en) * | 1990-07-16 | 1998-12-15 | Synenki; Richard M. | Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof |
US5310882A (en) * | 1990-11-30 | 1994-05-10 | American Cyanamid Company | Somatotropins with alterations in the α-helix 3 region |
NZ260103A (en) * | 1990-11-30 | 1996-10-28 | Bio Technology General Corp | Somatotropin with alterations in the alpha-helix-1 region |
GB9100381D0 (en) * | 1991-01-09 | 1991-02-20 | Erba Carlo Spa | Human bfgf derivatives,their analogs and process for their production |
FR2671554A1 (fr) * | 1991-01-11 | 1992-07-17 | Clonatec Sa | Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b. |
AU654563B2 (en) * | 1991-07-24 | 1994-11-10 | Imperial Chemical Industries Plc | Proteins |
ZA936811B (en) * | 1992-10-28 | 1995-03-15 | Upjohn Co | Somatotropin modifications |
US6753165B1 (en) | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US7270809B2 (en) | 1997-07-14 | 2007-09-18 | Bolder Biotechnology, Inc. | Cysteine variants of alpha interferon-2 |
US7153943B2 (en) | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
CN1269805A (zh) | 1997-07-14 | 2000-10-11 | 博尔德生物技术公司 | 生长激素和相关蛋白的衍生物 |
US7495087B2 (en) | 1997-07-14 | 2009-02-24 | Bolder Biotechnology, Inc. | Cysteine muteins in the C-D loop of human interleukin-11 |
US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
CA2408851C (en) | 2000-05-16 | 2011-07-12 | Bolder Biotechnology, Inc. | Methods for refolding proteins containing free cysteine residues |
US6878861B2 (en) | 2000-07-21 | 2005-04-12 | Washington State University Research Foundation | Acyl coenzyme A thioesterases |
US7060442B2 (en) | 2000-10-30 | 2006-06-13 | Regents Of The University Of Michigan | Modulators on Nod2 signaling |
WO2004022593A2 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
US7998930B2 (en) | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
US8329866B2 (en) | 2005-10-03 | 2012-12-11 | Bolder Biotechnology, Inc. | Long acting VEGF inhibitors and methods of use |
WO2007044382A2 (en) | 2005-10-07 | 2007-04-19 | Health Protection Agency | Proteins with improved solubility and methods for producing and using same |
EP2102355B1 (en) | 2006-12-14 | 2016-03-02 | Bolder Biotechnology, Inc. | Long acting proteins and peptides and methods of making and using the same |
BRPI0917000A2 (pt) * | 2008-08-06 | 2016-02-16 | Novo Nordisk Healthcare Ag | proteínas conjugadas com eficácia in vivo prolongada |
JP5816097B2 (ja) | 2009-01-22 | 2015-11-18 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | 安定な成長ホルモン化合物 |
CN105963710A (zh) | 2009-08-06 | 2016-09-28 | 诺沃—诺迪斯克保健股份有限公司 | 具有延长的体内功效的生长激素 |
EP2805964A1 (en) * | 2009-12-21 | 2014-11-26 | Ambrx, Inc. | Modified bovine somatotropin polypeptides and their uses |
MX2012006980A (es) * | 2009-12-21 | 2012-07-17 | Ambrx Inc | Polipeptidos de somatotropina porcina modificados y sus usos. |
AU2011208620B2 (en) | 2010-01-22 | 2015-04-16 | Novo Nordisk Health Care Ag | Stable growth hormone compounds |
CN118767116A (zh) | 2010-01-22 | 2024-10-15 | 诺沃—诺迪斯克保健股份有限公司 | 体内功效延长的生长激素 |
TR201910573T4 (tr) * | 2012-08-31 | 2019-08-21 | Glaxosmithkline Biologicals Sa | Staphylococcus aureus'a karşı bağışıklık kazandırmak için stabilize edilmiş proteinler. |
EP2981282B1 (en) | 2013-04-05 | 2020-11-04 | Novo Nordisk Health Care AG | Growth hormone compound formulation |
KR20180003677A (ko) * | 2016-06-30 | 2018-01-10 | 주식회사 크레아플래닛 | 인간 성장호르몬 변이 단백질 또는 이의 트랜스페린 융합 단백질을 유효성분으로 포함하는 약학적 조성물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443539A (en) * | 1980-02-05 | 1984-04-17 | The Upjohn Company | Process for preparing bovine growth hormone |
FI82266C (fi) * | 1982-10-19 | 1991-02-11 | Cetus Corp | Foerfarande foer framstaellning av il-2 -mutein. |
US4774091A (en) * | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
US4855238A (en) * | 1983-12-16 | 1989-08-08 | Genentech, Inc. | Recombinant gamma interferons having enhanced stability and methods therefor |
US4959314A (en) * | 1984-11-09 | 1990-09-25 | Cetus Corporation | Cysteine-depleted muteins of biologically active proteins |
US4761289A (en) * | 1986-10-10 | 1988-08-02 | International Minerals & Chemical Corp. | Sustained release implant and method for preparing same |
US5079230A (en) * | 1988-09-12 | 1992-01-07 | Pitman-Moore, Inc. | Stable bioactive somatotropins |
KR910700264A (ko) * | 1989-01-19 | 1991-03-14 | 로버트 에이. 아미테이지 | 소마토트로핀 유사물 |
EP0456642A1 (en) * | 1989-01-31 | 1991-11-21 | The Upjohn Company | Somatotropin analogs |
US5849694A (en) * | 1990-07-16 | 1998-12-15 | Synenki; Richard M. | Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof |
-
1989
- 1989-07-27 DE DE68929273T patent/DE68929273T2/de not_active Expired - Fee Related
- 1989-07-27 EP EP89113852A patent/EP0355460B1/en not_active Expired - Lifetime
- 1989-07-27 ES ES89113852T patent/ES2154627T3/es not_active Expired - Lifetime
- 1989-07-27 AT AT89113852T patent/ATE198353T1/de not_active IP Right Cessation
- 1989-07-30 IL IL9115689A patent/IL91156A/en not_active IP Right Cessation
- 1989-08-17 NZ NZ230342A patent/NZ230342A/en unknown
- 1989-08-22 PT PT91512A patent/PT91512B/pt not_active IP Right Cessation
- 1989-08-23 AR AR89314728A patent/AR245138A1/es active
- 1989-08-23 NO NO89893387A patent/NO893387L/no unknown
- 1989-08-23 IE IE270689A patent/IE892706A1/en unknown
- 1989-08-23 DK DK416589A patent/DK416589A/da not_active Application Discontinuation
- 1989-08-23 YU YU01632/89A patent/YU163289A/xx unknown
- 1989-08-23 JP JP1217185A patent/JP2894355B2/ja not_active Expired - Lifetime
- 1989-08-23 HU HU894322A patent/HU217095B/hu not_active IP Right Cessation
- 1989-08-23 FI FI893963A patent/FI104908B/fi not_active IP Right Cessation
- 1989-08-24 AU AU40202/89A patent/AU630105B2/en not_active Ceased
-
1995
- 1995-05-09 US US08/437,578 patent/US5891840A/en not_active Expired - Fee Related
-
2001
- 2001-03-20 GR GR20010400454T patent/GR3035608T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU4020289A (en) | 1990-03-15 |
HUT51331A (en) | 1990-04-28 |
EP0355460A2 (en) | 1990-02-28 |
HU217095B (hu) | 1999-11-29 |
NO893387D0 (no) | 1989-08-23 |
YU163289A (en) | 1992-05-28 |
DE68929273D1 (de) | 2001-02-01 |
EP0355460B1 (en) | 2000-12-27 |
JPH034797A (ja) | 1991-01-10 |
IE892706A1 (en) | 1991-01-16 |
IE892706L (en) | 1990-02-24 |
FI893963A (fi) | 1990-02-25 |
DK416589D0 (da) | 1989-08-23 |
PT91512B (pt) | 1995-05-31 |
PT91512A (pt) | 1990-03-08 |
NZ230342A (en) | 1992-08-26 |
ES2154627T3 (es) | 2001-04-16 |
DE68929273T2 (de) | 2001-07-05 |
FI893963A0 (fi) | 1989-08-23 |
AR245138A1 (es) | 1993-12-30 |
US5891840A (en) | 1999-04-06 |
EP0355460A3 (en) | 1991-04-03 |
IL91156A (en) | 1995-05-26 |
DK416589A (da) | 1990-02-25 |
FI104908B (fi) | 2000-04-28 |
IL91156A0 (en) | 1990-03-19 |
AU630105B2 (en) | 1992-10-22 |
JP2894355B2 (ja) | 1999-05-24 |
ATE198353T1 (de) | 2001-01-15 |
GR3035608T3 (en) | 2001-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO893387L (no) | Stabilisering av somatotropiner ved modifikasjon av cysteinrester med sete-rettet mutagenese eller kjemisk derivatisering. | |
FI895778A0 (fi) | Anlaeggning foer foerstoering av aerosol- och/eller frysmedel. | |
FI912565A0 (fi) | Absorptiokappale | |
NO166032C (no) | Fremgangsmaate ved fremstilling av triklormonosilan. | |
NO895067L (no) | Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose eller alfa, d-allofuranose. | |
NO892068D0 (no) | Fremgangsmaate ved fremstilling av naftatiozepinoner. | |
NO894173L (no) | Fremgangsmaate ved fremstilling av kloridoksid. | |
FI902100A0 (fi) | Foerpackning foer upphettande eller kokande av en matprodukt i en hetluftsugn. | |
FI896203A (fi) | En eller flerskikts inloppslaoda med utvidgad rwglerzon av genomloppsvolym. | |
FI904676A0 (fi) | Anordning foer loesgoerande av manteln i en haeftapparat. | |
FI882949A (fi) | Foerfarande foer xerografisk tryckning av textilmaterial eller dylikt. | |
FI884618A (fi) | Anordning foer taendning och stabilisering av en svetsbaoge. | |
NO891898D0 (no) | Fremgangsmaate ved fremstilling av naftotiazepinoner. | |
FI900835A0 (fi) | Taetning med reglerbar diameter. | |
FI880733A0 (fi) | Anordning foer uppbaerning av solv- eller rittgarn i en vaevstol. | |
FI902087A0 (fi) | Anordning foer styrning av likriktare. | |
KR890017723U (ko) | 금고문의 전자식 괘, 해정장치 | |
FI880029A0 (fi) | Anordning foer sammanfogning av byggelement. | |
FI896348A (fi) | Anordning foer bearbetning av stenelement, speciellt hoernstenelement foer en eldstad. | |
FI894354A (fi) | Formanordning foer bildande av ett vattenavledningsspaor i asfaltkanten. | |
NO883849L (no) | Anordning ved gassreguleringsanordning eller liknende. | |
FI883463A (fi) | Anordning foer undervattensarbete. | |
FI884390A (fi) | Anordning foer begraensning av tryck i gas eller vaetska. | |
NO912140D0 (no) | Absorpsjonslegeme. | |
ES1009886Y (es) | Ba era de estructura compuesta. |